HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

miR-200b-3p antagomir inhibits neuronal apoptosis in oxygen-glucose deprivation (OGD) model through regulating β-TrCP.

AbstractBACKGROUND:
Hypoxia-ischemic brain damage (HIBD) is a primary cause of morbidity and disability in survivors of preterm infants. We previously discovered that miR-200b-3p plays an important role in HIBD via targeting Slit2. This study was designed to identify novel targets of miR-200b-3p and investigate the relationship between miR-200b-3p and its downstream effectors.
METHODS AND RESULTS:
Cultured primary rat hippocampal neurons were used in the model of oxygen-glucose deprivation (OGD) and RT-qPCR was utilized to detect the alterations of miR-200b-3p in these cells following the OGD. Our study found that the expression of miR-200b-3p was up-regulated in neurons post OGD. Bioinformatics analysis identified that β transducin repeat-containing protein (β-TrCP) is a target gene of miR-200b-3p, and our luciferase reporter gene assay confirmed that miR-200b-3p can interact with β-TrCP mRNA. Hypoxia-ischemic brain damage was induced in three-day-old SD rats and inhibition of miR-200b-3p by injection of antagomir into bilateral lateral ventricles enhanced β-TrCP expression at both the mRNA and protein levels in rats' brains. TUNEL staining and CCK-8 assays found that the survival of hippocampal neurons in the miR-200b-3p antagomir group was improved significantly (p<0.05), whereas apoptosis of neurons in the miR-200b-3p antagomir group was significantly decreased (p<0.05), as compared with the OGD group. However, silencing of β-TrCP by β-TrCP siRNA impaired the neuroprotective effect of miR-200b-3p antagomir. H&E staining showed that miR-200b-3p attenuated the pathological changes in the hippocampal region of rats with HIBD.
CONCLUSION:
Our study has demonstrated that β-TrCP is a target gene of miR-200b-3p and that inhibition of miR-200b-3p by antagomir attenuates hypoxia-ischemic brain damage via β-TrCP.
AuthorsNan Zhang, Lijun Yang, Jialin Wen, Hong Cui
JournalBrain research (Brain Res) Vol. 1800 Pg. 148192 (02 01 2023) ISSN: 1872-6240 [Electronic] Netherlands
PMID36463959 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2022 Elsevier B.V. All rights reserved.
Chemical References
  • Oxygen
  • MicroRNAs
  • beta-Transducin Repeat-Containing Proteins
  • Antagomirs
  • Glucose
  • RNA, Messenger
Topics
  • Infant, Newborn
  • Humans
  • Rats
  • Animals
  • Oxygen (metabolism)
  • MicroRNAs (metabolism)
  • beta-Transducin Repeat-Containing Proteins (pharmacology)
  • Antagomirs (pharmacology)
  • Rats, Sprague-Dawley
  • Glucose (pharmacology)
  • Infant, Premature
  • Hypoxia-Ischemia, Brain (pathology)
  • Apoptosis
  • RNA, Messenger

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: